SUBJECTS : Cancer Research | Clinical Oncology | Cancer Genetics | Molecular Targets | Surgical Oncolog
LATEST MANUSCRIPTS IN Frontiers in Oncology
- Kyaw Zwar Myint, Mireia Sueca-Comes, Pamela Collier, Brinda Balasubramanian, Simran Venkatraman, John Gordan, Abed M Zaitoun, Abhik Mukherjee, Arvind Arora, Noppadol Larbcharoensub, Chinnawut Suriyonplengsaeng, Kanokpan Wongprasert, Tavan Janvilisri, Dhanny Gomez, Anna M Grabowska, Rutaiwan Tohtong, David O Bates, Kiren Yacqub-Usman. Preclinical evidence for anaplastic lymphoma kinase inhibitors as novel therapeutic treatments for cholangiocarcinoma. Frontiers in oncology. 2023, 13: 1184900
Cited : 1Read More - Selene Cipri, Francesco Fabozzi, Giada Del Baldo, Giuseppe Maria Milano, Luigi Boccuto, Andrea Carai, Angela Mastronuzzi. Targeted therapy for pediatric central nervous system tumors harboring mutagenic tropomyosin receptor kinases. Frontiers in oncology. 2023, 13: 1235794Cited : 0Read More
- Jun Wang, Zhong-Zheng Xiang, Chen-Feng Tan, Yuan-Yuan Zeng, Tian Yang, Xiao-Yuan Wei, Si-Ting Yu, Ze-Lei Dai, Ning-Yue Xu, Lei Liu. Individualized 3D-printed bolus promotes precise postmastectomy radiotherapy in patients receiving breast reconstruction. Frontiers in oncology. 2023, 13: 1239636Cited : 0Read More
- Yiping Xin, Qi Zhang, Xinyuan Liu, Bingqing Li, Tao Mao, Xiaoyu Li. Application of artificial intelligence in endoscopic gastrointestinal tumors. Frontiers in oncology. 2023, 13: 1239788Cited : 0Read More
- Lu Ye, Fei Zhou, Dongdong Cheng, Ming Xie, Xiaoli Yan, Yuyu Xue, Qian Yang, Rong Jia, Lili Zhong, Li Yang, Liqun Zou, Na Huang. Efficacy and safety of anti-CD38 monoclonal antibodies in patients with relapsed/refractory multiple myeloma: a systematic review and meta-analysis with trial sequential analysis of randomized controlled trials. Frontiers in oncology. 2023, 13: 1240318Cited : 0Read More
- Ranodeep Chatterjee, Aditya Shukla, Kausiki Chakrabarti, Urmi Chatterji. CLEC12A sensitizes differentially responsive breast cancer cells to the anti-cancer effects of artemisinin by repressing autophagy and inflammation. Frontiers in oncology. 2023, 13: 1242432Cited : 0Read More
- Shijie Jin, Liyi Wu, Zhen Liang, Weigang Yan. The prognostic value of zonal origin in clinically localized prostate cancer: a systematic review and meta-analysis. Frontiers in oncology. 2023, 13: 1248222Cited : 0Read More
- Kazuki Heishima, Naohiko Aketa, Mizuki Heishima, Asuka Kawachi. Hemangiosarcoma in dogs as a potential non-rodent animal model for drug discovery research of angiosarcoma in humans. Frontiers in oncology. 2023, 13: 1250766Cited : 0Read More
- Justin C Brown, Stephanie L E Compton, Jeffrey A Meyerhardt, Guillaume Spielmann, Shengping Yang. The dose-response effect of aerobic exercise on inflammation in colon cancer survivors. Frontiers in oncology. 2023, 13: 1257767Cited : 1Read More
- Minal Çalışkan, Koichi Tazaki. AI/ML advances in non-small cell lung cancer biomarker discovery. Frontiers in oncology. 2023, 13: 1260374Cited : 1Read More
- Johnny Kao, Michelle Sahagian, Vani Gupta, Symeon Missios, Ashish Sangal. Long-term disease-free survival following comprehensive involved site radiotherapy for oligometastases. Frontiers in oncology. 2023, 13: 1267626Cited : 0Read More
- Fabio Giannone, Nevena Slovic, Patrick Pessaux, Catherine Schuster, Thomas F Baumert, Joachim Lupberger. Inflammation-related prognostic markers in resected hepatocellular carcinoma. Frontiers in oncology. 2023, 13: 1267870Cited : 2Read More
- Grzegorz Młynarczyk, Natalia Domian, Irena Kasacka. Changes in adhesion molecules: β-catenin, E-cadherin and Galectin-3 in cells of testicular seminoma. Frontiers in oncology. 2023, 13: 1269637Cited : 0Read More
- Jacob A Ford, Arjun Bhatt, Rachel C Kim, Michael Larkins, Aidan M Burke. Primary squamous cell carcinoma of the pancreas: an update on a rare neoplasm from the SEER database. Frontiers in oncology. 2023, 13: 1272740Cited : 0Read More
- Xunbo Zheng, Li Han, Jun Guan, Chenteng Chen, Yue Zhang, Jiali Zhang, Yiran Zhang, Siyao Liu, Junyan Su, Mengyuan Liu, Hanxing Huang. serves as a prognostic biomarker in lung adenocarcinoma with implications in RNA epigenetic modification, DDR pathway, and RNA metabolism. Frontiers in oncology. 2023, 13: 1274439Cited : 0Read More
